Genentech Ophthalmology Co-pay Program - Vabysmo
Genentech, Inc. (Roche) · Vabysmo
Patient pays: as little as $0 per treatment
commercial insurance
Patient assistance
Tell us your insurance and household details. We’ll show you every Vabysmo assistance program you may qualify for - the real manufacturer and foundation programs, not a discount card - with sources and a direct link to apply. About a minute, no login.
Vabysmo help that still works on Medicare or Medicaid - the programs copay cards leave out.
Vabysmo (faricimab-svoa) is an anti-vegf and anti-ang2 bispecific antibody (intravitreal) made by Roche / Genentech. It is commonly prescribed for: Neovascular (wet) age-related macular degeneration, Diabetic macular edema, Macular edema following retinal vein occlusion.
Tell us five things. We’ll do the rest.
Reference
This is the full list before we filter by your situation. Use the calculator above to see only the ones you may qualify for.
Genentech, Inc. (Roche) · Vabysmo
Patient pays: as little as $0 per treatment
commercial insurance
Genentech, Inc. (Roche) · Vabysmo
uninsured · underinsured
Common questions
Related drugs